At the Financial Times Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.
Don Tracy
Advertisement
Articles by Don Tracy
Advertisement
Latest Updated Articles
Advertisement
Advertisement
